United Capital Financial Advisers, LLC Indaptus Therapeutics, Inc. Transaction History
United Capital Financial Advisers, LLC
- $19.9 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
605KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$225,5130.0% of portfolio
-
Investment House LLC Las Vegas, NV100KShares$87,9780.01% of portfolio
-
Geode Capital Management, LLC Boston, MA73.1KShares$64,3530.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$39,8950.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44KShares$38,7050.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $7.27M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...